Meilan M. Rutter, MD
- Medical Director, Differences of Sex Development (DSD) Center
- Professor, UC Department of Pediatrics
- meilan.rutter@cchmc.org
- Board Certified
About
Biography
I am board-certified in pediatric endocrinology and have been on the faculty of Cincinnati Children’s Hospital Medical Center and the University of Cincinnati since 2008. I completed my training in the United Kingdom, New Zealand, and Cincinnati. I serve as the medical director of the Cincinnati Children’s Differences of Sex Development (DSD) Center and the assistant director of the pediatric endocrinology fellowship training program.
I care for children and adolescents with a wide spectrum of endocrine conditions, including growth, puberty, thyroid, and adrenal disorders. I collaborate with interdisciplinary specialists to deliver the endocrine aspects of comprehensive and integrated care for patients with complex conditions. I lead the Cincinnati Children’s DSD Center, which provides interdisciplinary care for people born with conditions affecting reproductive development. The DSD Center is a member of the DSD-Translational Research Network, a national network that strives to optimize and standardize clinical practices and advance scientific knowledge in this field. I also serve as the primary endocrine consultant for the Cincinnati Comprehensive Neuromuscular Center. In conjunction with the neuromuscular team, I have helped pioneer global awareness of the importance of endocrine issues in patients affected by Duchenne Muscular Dystrophy.
MB, BCh: University of Wales College of Medicine, Cardiff, United Kingdom
FRACP: Royal Australasian College of Physicians, New Zealand
Residency: University Hospital of Wales, Cardiff, United Kingdom
Residency: Auckland Children's Hospital and Dunedin Hospital, Auckland and Dunedin, New Zealand
Residency: Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Fellowship: Pediatric Endocrinology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Certifications: American Subspecialty Board of Pediatric Endocrinology, 2003, recertified 2013; American Board of Pediatrics, 2002; Fellow of the Royal Australasian College of Physicians (Pediatrics), 1995
Interests
Pediatric endocrinology, including growth, puberty, thyroid and adrenal disorders; differences of sex development, or conditions affecting reproductive development; endocrine and bone health in neuromuscular conditions
Services and Specialties
- Diabetes
- Differences of Sex Development (DSD) Center
- Endocrinology
- Endocrinology Diagnostic Lab
- Fanconi Anemia
- Leukemia and Lymphoma
- Comprehensive Neuromuscular Disorders
- The 22Q-Velocardiofacial Syndrome Center
Interests
Differences of sex development; endocrine issues and bone health associated with Duchenne muscular dystrophy
Research Areas
Additional Languages
French, MandarinLocations (2)
Insurance Information
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Publications
Optimizing Care for Growth and Puberty in Duchenne Muscular Dystrophy: A Survey of Clinical Practice in the OPTIMIZE DMD Consortium. Muscle and Nerve. 2026; 74(2):433-439.
Navigating sexual health, fertility, and adult wellness in individuals with Duchenne muscular dystrophy: Current standards of care and future directions. Journal of Neuromuscular Diseases. 2026; 22143602261454423.
From X to Y and everything in between: navigating care for patients with 45,X/46,XY mosaicism. Endocrine Abstracts. 2026.
Caring for Gender Diverse Youth With Duchenne Muscular Dystrophy: A Multisite Case Series. Pediatric Neurology. 2026; 179:87-90.
From case to caution: hyponatremia in a patient with Duchenne muscular dystrophy on vamorolone and lessons for clinicians. Neuromuscular Disorders. 2026; 62:106411.
The burden of bone disease in Duchenne muscular dystrophy: age-specific prevalence of osteoporosis and low bone density. Osteoporosis International. 2026; 37(5):1319-1328.
Acute Adverse Events Following Intravenous Bisphosphonate Infusion Are Uncommon in Patients With Duchenne Muscular Dystrophy Previously Treated With Oral Bisphosphonates. Muscle and Nerve. 2026; 73(3):445-451.
Adrenal Suppression in Duchenne Muscular Dystrophy: Management Strategies Incorporating Novel Steroid Vamorolone. Journal of the Endocrine Society. 2026; 10(2):bvaf181.
Defining Success in the Delivery of Fertility-Related Care for Patients with Differences of Sex Development. Hormone Research in Paediatrics. 2026; 99(1):81-90.
MON-474 Adrenal Control in Pediatric 11β-Hydroxylase Deficient CAH Patients Using Different Hydrocortisone Formulations: A Two-Patient Case Study. Journal of the Endocrine Society. 2025; 9(Supplement_1):bvaf149.1731.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 2026 Cincinnati Children's Hospital Medical Center. All rights reserved.
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent experience management company, Qualtrics. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey